Cargando…
Cognitive impairment and medication adherence post-stroke: A five-year follow-up of the ASPIRE-S cohort
BACKGROUND: Control of vascular risk factors is essential for secondary stroke prevention. However, adherence to secondary prevention medications is often suboptimal, and may be affected by cognitive impairment. Few studies to date have examined associations between cognitive impairment and medicati...
Autores principales: | Rohde, Daniela, Gaynor, Eva, Large, Margaret, Mellon, Lisa, Bennett, Kathleen, Williams, David J., Brewer, Linda, Hall, Patricia, Callaly, Elizabeth, Dolan, Eamon, Hickey, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797135/ https://www.ncbi.nlm.nih.gov/pubmed/31622438 http://dx.doi.org/10.1371/journal.pone.0223997 |
Ejemplares similares
-
Secondary prevention and cognitive function after stroke: a study protocol for a 5-year follow-up of the ASPIRE-S cohort
por: Rohde, Daniela, et al.
Publicado: (2017) -
Secondary prevention after ischaemic stroke: the ASPIRE-S study
por: Brewer, Linda, et al.
Publicado: (2015) -
Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study
por: Mellon, Lisa, et al.
Publicado: (2015) -
Does cognitive impairment impact adherence? A systematic review and meta-analysis of the association between cognitive impairment and medication non-adherence in stroke
por: Rohde, Daniela, et al.
Publicado: (2017) -
Stroke warning campaigns: delivering better patient outcomes? A systematic review
por: Mellon, Lisa, et al.
Publicado: (2015)